Gordon Rubenfeld | The Bioethics of Intensive Care
Isabel Bader Theatre
Everyone is welcome.
Who lives? Who dies? Who pays? Who decides? The Bioethics of Intensive Care
Date: Jan. 17, 2024
Speaker: Gordon Rubenfeld
Gordon Rubenfeld is Professor of Medicine at the University of Toronto and a practicing critical care physician. He was the inaugural Chief of the Program in Trauma, Emergency, and Critical Care at Sunnybrook Health Sciences Centre. Dr. Rubenfeld received his undergraduate degree in Philosophy and Comparative Literature at Johns Hopkins University; his medical degree from Jefferson Medical College; his internal medicine training at Duke University; and pulmonary and critical care training at the University of Washington. He received additional research training in clinical epidemiology as a Robert Wood Johnson Clinical Scholar at UCSF. He served on numerous professional society committees for the American Thoracic Society including the Bioethics, Critical Care Long Range Planning, Health Policy, and as Chair of the Critical Care Assembly. He directed the Advanced Clinical Research section of the Methods in Epidemiologic, Clinical and Operations Research course administered by the ATS. He has served on the editorial boards of the American Journal of Respiratory and Critical Care Medicine, Respiratory Care, the Journal of Critical Care, Critical Care, Lancet-Respiratory Medicine, and JAMA-Network Open. He served on numerous advisory panels and consensus groups in critical care including the American European Consensus Conference on Acute Lung Injury, the working group that developed the Berlin ARDS Definition, the LUNG-SAFE steering committee, and the Surviving Sepsis guideline committee. He has served on study sections for the National Institutes of Health and the Canadian Institutes of Health Research.
Dr. Rubenfeld’s research focuses on the clinical epidemiology and outcomes of critical illness syndromes, the transfer of evidence into clinical practice, and end-of-life care issues in the ICU. His research is funded primarily by the National Institutes of Health. Ongoing projects include a trial of interventions to increase use of lung protective ventilation in patients with acute lung injury, a randomized trial to improve long-term outcomes in survivors of prolonged mechanical ventilation, and a randomized trial of pre-hospital resuscitation for sepsis.
About Vic One Plenary
The Vic One Plenary session is a weekly guest lecture series, exposing students to different areas of investigation. The plenaries are meant to encourage open-minded discussion and ignite intellectual curiosity. Rather than an academic commitment, these sessions present another opportunity for students to gather and reflect.